Skip to main content

Advertisement

Log in

Does Any Imaging Method Allow Distinguishing Between Myoma and Sarcoma?

Current Obstetrics and Gynecology Reports Aims and scope Submit manuscript

Abstract

Myomas are the most common benign tumors of the uterus and can be found in 77 % of all hysterectomies, whereas uterine sarcoma is a very rare disease with a poor prognosis. The clinical characteristics of uterine fibroids and sarcoma are often similar. A history of pelvic irradiation, lung metastases, and missing response to different fibroid treatments can give hints toward uterine sarcoma. A spectrum of MRI findings has been described, but there are no pathognomonic features on any imaging technique.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435–8.

    CAS  PubMed  Google Scholar 

  2. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215–23.

    Article  PubMed  Google Scholar 

  3. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3):409–15.

    Article  PubMed  Google Scholar 

  4. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol. 2004;93(1):204–8.

    Article  PubMed  Google Scholar 

  5. Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol. 1994;83(3):414–8.

    CAS  PubMed  Google Scholar 

  6. Wysowski DK, Honig SF, Beitz J. Uterine sarcoma associated with tamoxifen use. N Engl J Med. 2002;346(23):1832–3.

    Article  PubMed  Google Scholar 

  7. Milman D, Zalel Y, Biran H, Open M, Caspi B, Hagay Z, et al. Unsuspected uterine leiomyosarcoma discovered during treatment with a gonadotropin-releasing hormone analogue: a case report and literature review. Eur J Obstet Gynecol Reprod Biol. 1998;76(2):237–40.

    Article  CAS  PubMed  Google Scholar 

  8. Baird DD, Garrett TA, Laughlin SK, Davis B, Semelka RC, Peddada SD. Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril. 2011;95(1):242–6.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Cicinelli E, Romano F, Anastasio PS, Blasi N, Parisi C, Galantino P. Transabdominal sonohysterography, transvaginal sonography, and hysteroscopy in the evaluation of submucous myomas. Obstet Gynecol. 1995;85(1):42–7.

    Article  CAS  PubMed  Google Scholar 

  10. Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10(12):1188–98.

    Article  PubMed  Google Scholar 

  11. Tamai K, Koyama T, Saga T, Morisawa N, Fujimoto K, Mikami Y, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol. 2008;18(4):723–30.

    Article  PubMed  Google Scholar 

  12. Namimoto T, Yamashita Y, Awai K, Nakaura T, Yanaga Y, Hirai T, et al. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol. 2009;19(11):2756–64.

    Article  PubMed  Google Scholar 

  13. Tanaka YO, Tsunoda H, Minami R, Yoshikawa H, Minami M. Carcinosarcoma of the uterus: MR findings. J Magn Reson Imaging. 2008;28(2):434–9.

    Article  PubMed  Google Scholar 

  14. Sahdev A, Sohaib SA, Jacobs I, Shepherd JH, Oram DH, Reznek RH. MR imaging of uterine sarcomas. AJR Am J Roentgenol. 2001;177(6):1307–11.

    Article  CAS  PubMed  Google Scholar 

  15. Kitajima K, Murakami K, Kaji Y, Sugimura K. Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol. 2010;195(3):737–43.

    Article  PubMed  Google Scholar 

  16. Sadeghi R, Zakavi SR, Hasanzadeh M, Treglia G, Giovanella L, Kadkhodayan S. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature. Int J Gynecol Cancer. 2013;23(8):1349–56.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

J. Serno, I. Meinhold-Heerlein, S. Schrading, and T. Papathemelis declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Papathemelis.

Additional information

This article is part of the Topical Collection on Uterine Fibroids

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Serno, J., Meinhold-Heerlein, I., Schrading, S. et al. Does Any Imaging Method Allow Distinguishing Between Myoma and Sarcoma?. Curr Obstet Gynecol Rep 4, 149–151 (2015). https://doi.org/10.1007/s13669-015-0121-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13669-015-0121-3

Keywords

Navigation